Literature DB >> 8053733

Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation.

P A Clavien1, C A Camargo, R Croxford, B Langer, G A Levy, P D Greig.   

Abstract

OBJECTIVE: This study defined negative outcomes of solid organ transplantation, proposed a new classification of complications by severity, and applied the classification to evaluate the results of orthotopic liver transplantation (OLT). SUMMARY AND BACKGROUND DATA: The lack of uniform reporting of negative outcomes has made reports of transplantation procedures difficult to interpret and compare. In fact, only mortality is well reported; morbidity rates and severity of complications have been poorly described.
METHODS: Based on previous definition and classification of complications for general surgery, a new classification for transplantation in four grades is proposed. Results including risk factors of the first 215 OLTs performed at the University of Toronto have been evaluated using the classification.
RESULTS: All but two patients (99%) had at least one complication of any kind, 92% of patients surviving more than 3 months had grade 1 (minor) complications, 74% had grade 2 (life-threatening) complications, and 30% had grade 3 (residual disability or cancer) complications. Twenty-nine per cent of patients had grade 4 complications (retransplantation or death). The most common grade 1 complications were steroid responsive rejection (69% of patients) and infection that did not require antibiotics or invasive procedures (23%). Grade 2 complications primarily were infection requiring antibiotics or invasive procedures (64%), postoperative bleeding requiring > 3 units of packed red cells (35%), primary dysfunction (26%), and biliary disease treated with antibiotics or requiring invasive procedures (18%). The most frequent grade 3 complication was renal failure, which is defined as a permanent rise in serum creatinine levels > or = twice the pretransplantation values (11%). Grade 4 complications (retransplantation or death) mainly were infection (14%) and primary dysfunction (11%). Comparison between the first and last 50 OLTs of the series indicates a significant decrease in the mean number of grade 1 and 2 complications. This was partially a result of better medical status of patients at the time of transplantation. Using univariate and multivariate analyses of risk factors, the best predictor of grade 1 complications was donor obesity; for grade 2 complications, the best predictor was a donor liver rewarming time of > 90 minutes, and for grade 3 and 4 complications, the best predictor was the APACHE II scoring system and donor cardiac arrest.
CONCLUSIONS: Standardized definitions and classifications of complications of transplantation will allow us to better evaluate and compare results of transplantation among centers and over time, and better compare effectiveness of new therapies. Orthotopic liver transplantation still is a procedure with high morbidity that requires careful analysis of risk factors to optimize selection of patients and organ sharing.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053733      PMCID: PMC1234350          DOI: 10.1097/00000658-199408000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  35 in total

Review 1.  Transplantation in the nineties.

Authors:  M R First
Journal:  Transplantation       Date:  1992-01       Impact factor: 4.939

2.  Analysis of warm ischemia time for prediction of primary nonfunction of the hepatic graft.

Authors:  C Cisneros; F Guillén; R Gomez; J Gutierrez; P Vorwald; A Montero; E Moreno
Journal:  Transplant Proc       Date:  1991-06       Impact factor: 1.066

Review 3.  Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies.

Authors:  P A Clavien; P R Harvey; S M Strasberg
Journal:  Transplantation       Date:  1992-05       Impact factor: 4.939

4.  Apache-II-scoring in the liver transplant recipient.

Authors:  T Bein; H Forst; E Pratschke
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

5.  Proposed classification of complications of surgery with examples of utility in cholecystectomy.

Authors:  P A Clavien; J R Sanabria; S M Strasberg
Journal:  Surgery       Date:  1992-05       Impact factor: 3.982

6.  Recent developments in liver transplantation. Lessons from a 5-year experience.

Authors:  J B Otte
Journal:  J Hepatol       Date:  1991-05       Impact factor: 25.083

7.  The outcomes movement--will it get us where we want to go?

Authors:  A M Epstein
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

8.  Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease.

Authors:  S Todo; A J Demetris; D Van Thiel; L Teperman; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

9.  Excessive weight gain after liver transplantation.

Authors:  M Palmer; F Schaffner; S N Thung
Journal:  Transplantation       Date:  1991-04       Impact factor: 4.939

10.  Analysis of morbidity and mortality rates in right hepatectomy with the preoperative APACHE II score.

Authors:  M Gagner; D Franco; C Vons; C Smadja; R L Rossi; J W Braasch
Journal:  Surgery       Date:  1991-09       Impact factor: 3.982

View more
  89 in total

1.  Multivariate regression analysis on early mortality after orthotopic liver transplantation.

Authors:  Ye-Ben Qian; Gui-Hua Cheng; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Contemporary single-center surgical experiences in redo procedures of the pancreas: improved outcome and reduction of operative risk.

Authors:  Sabine Kersting; Monika Silvia Janot; Ansgar Michael Chromik; Dominique Suelberg; Waldemar Uhl; Matthias Hartmut Seelig
Journal:  J Gastrointest Surg       Date:  2010-11-12       Impact factor: 3.452

Review 3.  Adult-to-adult living donor liver transplantation.

Authors:  Shimul A Shah; Gary A Levy; Lesley D Adcock; Gary Gallagher; David R Grant
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

Review 4.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

5.  What is a surgical complication?

Authors:  Daniel K Sokol; James Wilson
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

6.  Striving for a better operative outcome: 101 pancreaticoduodenectomies.

Authors:  A W C Kow; S P Chan; A Earnest; C Y Chan; K Lim; S Y Chong; K H Lim; C K Ho; S P Chew; K H Liau
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 7.  Living donor liver transplantation: eliminating the wait for death in end-stage liver disease?

Authors:  Robert A Fisher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-02-15       Impact factor: 46.802

8.  Evolution of donor morbidity in living related liver transplantation: a single-center analysis of 165 cases.

Authors:  Dieter C Broering; Christian Wilms; Pamela Bok; Lutz Fischer; Lars Mueller; Christian Hillert; Christian Lenk; Jong-Sun Kim; Martina Sterneck; Karl-Heinz Schulz; Gerrit Krupski; Axel Nierhaus; Detlef Ameis; Martin Burdelski; Xavier Rogiers
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

9.  Laparoscopic Gynae-oncological Procedures: Lessons Learnt After a Single Institution Audit of Complications and Their Management in 567 Consecutive Patients.

Authors:  Shailesh P Puntambekar; Geetanjali A Agrawal; Saurabh N Joshi; Neeraj V Rayate; D N B Saravana; Avanish V Deshmukh
Journal:  J Obstet Gynaecol India       Date:  2013-08-13

10.  Adult-to-adult living donor liver transplantation for acute liver failure in China.

Authors:  Ding Yuan; Fei Liu; Yong-Gang Wei; Bo Li; Lv-Nan Yan; Tian-Fu Wen; Ji-Chun Zhao; Yong Zeng; Ke-Fei Chen
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.